Analystreport

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.

TETRAPHASE PHARMACEUTICALS INC  (TTPH) 
Last tetraphase pharmaceuticals inc earnings: 3/11 09:29 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tphase.com/investor-relations